COVID-19 is an emerging, rapidly evolving situation.
NIH, led by the National Institute of Allergy and Infectious Diseases (NIAID), is helping to support research and researchers following an outbreak of COVID-19, an acute respiratory illness caused by the novel coronavirus SARS-CoV-2.
Institutes, Centers and Offices across the National Institutes of Health (NIH) are engaged in global health research and research training activities.
Fogarty and a dozen partners across NIH invested nearly $80 million to establish noncommunicable diseases research partnerships between U.S. and LMIC institutions, and build related research training programs.
With support from the
National Institute of Mental Health (NIMH), Fogarty and other NIH institutes, researchers are studying ways to reduce global suicides.
National Institute of Allergy and Infectious Diseases (NIAID) research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people in the U.S. and around the world.
More global health research news
Updated March 2020